We are live on ! Find out more
NIM

NEOS Investment Management Portfolio holdings

AUM $27.1B
1-Year Est. Return 57.21%
This Fund
S&P 500
This Quarter Est. Return
-2.03%
1 Year Est. Return
+57.21%
3 Year Est. Return
+163.05%
5 Year Est. Return
10 Year Est. Return
AUM
$19.8B
AUM Growth
+$2.5B
Cap. Flow
+$3.5B
Cap. Flow %
17.7%
Top 10 Hldgs %
39.03%
Holding
664
New
14
Increased
467
Reduced
94
Closed
89

Top Buys

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$333M
2
NVDA icon
NVIDIA
NVDA
+$242M
3
VTWO icon
Vanguard Russell 2000 ETF
VTWO
+$218M
4
AAPL icon
Apple
AAPL
+$213M
5
MSFT icon
Microsoft
MSFT
+$176M

Sector Composition

Rank Sector Weight
1 Technology 38.36%
2 Communication Services 12.13%
3 Consumer Discretionary 10.25%
4 Healthcare 6.37%
5 Consumer Staples 6.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MOH icon
626
Molina Healthcare
MOH
$10.2B
-1,693
Closed -$294K
MTCH icon
627
Match Group
MTCH
$8.45B
-36,448
Closed -$1.18M
NBIX icon
628
Neurocrine Biosciences
NBIX
$16.5B
-3,548
Closed -$503K
NRIX icon
629
Nurix Therapeutics
NRIX
$2.69B
-77,775
Closed -$1.48M
NTLA icon
630
Intellia Therapeutics
NTLA
$1.68B
-14,260
Closed -$128K
NUVB icon
631
Nuvation Bio
NUVB
$2.24B
-247,508
Closed -$2.22M
NUVL
632
DELISTED
Nuvalent
NUVL
-37,003
Closed -$3.72M
NVT icon
633
nVent Electric
NVT
$27.1B
-66,027
Closed -$6.73M
OGE icon
634
OGE Energy
OGE
$9.57B
-219,650
Closed -$9.38M
OLMA icon
635
Olema Pharmaceuticals
OLMA
$913M
-45,170
Closed -$1.13M
ORIC icon
636
Oric Pharmaceuticals
ORIC
$1.42B
-28,269
Closed -$231K
PFGC icon
637
Performance Food Group
PFGC
$17.9B
-27,814
Closed -$2.5M
POWL icon
638
Powell Industries
POWL
$7.59B
-229,014
Closed -$24.3M
RCUS icon
639
Arcus Biosciences
RCUS
$3.66B
-36,665
Closed -$874K
REPL icon
640
Replimune Group
REPL
$1.15B
-52,052
Closed -$506K
RKT icon
641
Rocket Companies
RKT
$40.5B
-34,875
Closed -$675K
RLAY icon
642
Relay Therapeutics
RLAY
$4.38B
-113,230
Closed -$958K
RVMD icon
643
Revolution Medicines
RVMD
$44.1B
-101,888
Closed -$8.12M
SDGR icon
644
Schrodinger
SDGR
$1.4B
-20,373
Closed -$364K
SMMT icon
645
Summit Therapeutics
SMMT
$12.1B
-97,217
Closed -$1.7M
SNDX icon
646
Syndax Pharmaceuticals
SNDX
$1.81B
-101,553
Closed -$2.13M
SPHY icon
647
State Street SPDR Portfolio High Yield Bond ETF
SPHY
$12B
-2,574,955
Closed -$60.9M
SPXC icon
648
SPX Corp
SPXC
$10.9B
-36,616
Closed -$7.33M
SRRK icon
649
Scholar Rock
SRRK
$6.34B
-9,899
Closed -$436K
TERN
650
DELISTED
Terns Pharmaceuticals
TERN
-10,394
Closed -$420K

Similar funds

NEOS Investment Management's Q1 2026 Portfolio in Review

As of Q1 2026, NEOS Investment Management held 664 positions worth $19.8B, up 14% from $17.3B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

NEOS Investment Management deployed $3.5B of net new capital in Q1 2026, opening 14 new positions and adding to 467 existing holdings. Its largest new stake was Enbridge: 841,618 shares worth $45.5M.

By sector, the portfolio is most concentrated in Technology at 38% of assets, down from 39% a quarter earlier, followed by Communication Services and Consumer Discretionary.

On the sell side, the largest reduction was Caterpillar, an estimated $19M trimmed.

  • NEOS Investment Management's largest Q1 2026 buy was Enbridge: 841,618 shares worth $45.5M.
  • NEOS Investment Management added most to Walmart Inc in Q1 2026, an estimated $333M increase.
  • NEOS Investment Management's biggest Q1 2026 reduction was Caterpillar, cutting an estimated $19M.
  • NEOS Investment Management fully exited iShares Broad USD High Yield Corporate Bond ETF in Q1 2026, selling an estimated $62.6M.
  • NEOS Investment Management's ten largest holdings make up 39% of its $19.8B portfolio in Q1 2026.
  • NEOS Investment Management opened 14 new positions and closed 89 in Q1 2026.
  • NEOS Investment Management's portfolio value rose 14% quarter-over-quarter to $19.8B.

Based on NEOS Investment Management's 13F filing for Q1 2026, filed 15 May 2026.